Everything old is new again: the case for imatinib as frontline therapy in 2017.

Everything old is new again: the case for imatinib as frontline therapy in 2017. Clin Adv Hematol Oncol. 2017 Apr;15(4):302-305 Authors: Lee SG, Lipton JH PMID: 28591105 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research